C4 Therapeutics Correlations

CCCC Stock

USD 3.94 0.08 2.07%

The current 90-days correlation between C4 Therapeutics and ELYM Old is -0.13 (i.e., Good diversification). The correlation of C4 Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

C4 Therapeutics Correlation With Market

Modest diversification

The correlation between C4 Therapeutics and DJI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in C4 Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For information on how to trade CCCC Stock refer to our How to Trade CCCC Stock guide.

Moving together with CCCC Stock

0.7	EQ	Equillium	Pair Corr
0.88	ME	23Andme Holding	Pair Corr
0.86	VALN	Valneva SE ADR	Pair Corr
0.83	DNLI	Denali Therapeutics	Pair Corr
0.84	DNTH	Dianthus Therapeutics	Pair Corr
0.74	DOMH	Dominari Holdings	Pair Corr
0.92	DRRX	Durect	Pair Corr
0.88	DTIL	Precision BioSciences	Pair Corr
0.9	VIGL	Vigil Neuroscience	Pair Corr
0.87	VINC	Vincerx Pharma	Pair Corr
0.88	VKTX	Viking Therapeutics	Pair Corr
0.73	VRCA	Verrica Pharmaceuticals	Pair Corr
0.89	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.74	VRPX	Virpax Pharmaceuticals	Pair Corr
0.77	VRTX	Vertex Pharmaceuticals	Pair Corr

Moving against CCCC Stock

0.87	VCEL	Vericel Corp Ord	Pair Corr
0.8	VCYT	Veracyte Potential Growth	Pair Corr
0.76	DRTS	Alpha Tau Medical	Pair Corr
0.67	DMAC	DiaMedica Therapeutics	Pair Corr
0.59	CDIOW	Cardio Diagnostics	Pair Corr
0.53	SABSW	SAB Biotherapeutics	Pair Corr
0.82	DYAI	Dyadic International	Pair Corr
0.73	VRNA	Verona Pharma PLC	Pair Corr
0.66	DVAX	Dynavax Technologies	Pair Corr
0.66	SRZNW	Surrozen Warrant	Pair Corr
0.65	VSTM	Verastem	Pair Corr
0.59	KTTAW	Pasithea Therapeutics	Pair Corr
0.43	VTRS	Viatris	Pair Corr
0.37	VYNE	Vyne Therapeutics	Pair Corr

Related Correlations Analysis

	STTK	ELYM	PRLD	GLUE	FHTX	CYT	RZLT	IPSC	EWTX	MLYS
STTK		0.48	0.69	-0.25	0.22	-0.05	0.37	0.36	0.25	0.43	STTK
ELYM	0.48		0.63	-0.06	0.7	-0.43	0.43	0.63	0.78	0.61	ELYM
PRLD	0.69	0.63		-0.51	0.23	-0.05	0.2	0.36	0.4	0.52	PRLD
GLUE	-0.25	-0.06	-0.51		0.47	-0.26	0.37	0.32	0.29	0.32	GLUE
FHTX	0.22	0.7	0.23	0.47		-0.46	0.63	0.76	0.89	0.68	FHTX
CYT	-0.05	-0.43	-0.05	-0.26	-0.46		0.13	-0.5	-0.61	-0.47	CYT
RZLT	0.37	0.43	0.2	0.37	0.63	0.13		0.39	0.48	0.5	RZLT
IPSC	0.36	0.63	0.36	0.32	0.76	-0.5	0.39		0.74	0.71	IPSC
EWTX	0.25	0.78	0.4	0.29	0.89	-0.61	0.48	0.74		0.75	EWTX
MLYS	0.43	0.61	0.52	0.32	0.68	-0.47	0.5	0.71	0.75		MLYS
	STTK	ELYM	PRLD	GLUE	FHTX	CYT	RZLT	IPSC	EWTX	MLYS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

EWTX	+ 0.89	FHTX
EWTX	+ 0.78	ELYM
IPSC	+ 0.76	FHTX
MLYS	+ 0.75	EWTX
EWTX	+ 0.74	IPSC
MLYS	+ 0.71	IPSC

High negative correlations

EWTX	- 0.61	CYT
GLUE	- 0.51	PRLD
IPSC	- 0.5	CYT
MLYS	- 0.47	CYT
CYT	- 0.46	FHTX
CYT	- 0.43	ELYM

Risk-Adjusted Indicators

There is a big difference between CCCC Stock performing well and C4 Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze C4 Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
STTK	4.17	(0.38)	0.00	1.02	0.00	0.00	10.62	(9.01)	22.78
ELYM	3.62	(1.07)	0.00	1.04	0.00	0.00	6.00	(9.35)	22.16
PRLD	4.66	(0.70)	0.00	(0.44)	0.00	0.00	11.20	(9.09)	55.77
GLUE	5.64	0.75	0.15	2.00	4.70	(8.18)	10.21	(8.46)	103.72
FHTX	3.27	(0.77)	0.00	(0.53)	0.00	0.00	5.05	(8.30)	20.44
CYT	2.76	0.56	0.15	4.91	2.57	(3.47)	10.00	(5.26)	36.14
RZLT	2.77	0.08	0.02	0.23	3.31	(3.04)	6.80	(5.95)	19.56
IPSC	3.92	(0.63)	0.00	(0.67)	0.00	0.00	6.73	(7.48)	31.00
EWTX	2.71	(0.26)	0.00	(0.13)	0.00	0.00	4.89	(5.54)	26.07
MLYS	3.37	(0.49)	0.00	(1.25)	0.00	0.00	7.79	(6.95)	26.52

C4 Therapeutics Corporate Management

Paige Mahaney	Chief Officer	Profile
Kelly Schick	Chief Officer	Profile
Isabel Chiu	Senior Development	Profile
Mr MBA	Chief Officer	Profile
Andrew Hirsch	Pres CEO	Profile
Leonard MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC